Johnson & Johnson Vaccine Usage Halted Due to Rare Blood Clots

Johnson & Johnson Vaccine Usage Halted Due to Rare Blood Clots

CDC Principal Deputy Director Dr. Anne Sccuchat and FDC Director for Biologics Evaluation and Research Peter Marks released a statement calling for the Johnson & Johnson (Janssen) vaccine administration to be paused as of April 13, 2021. They made this determination out of an abundance of caution after six cases of a rare and severe […]

Johnson & Johnson COVID-19 Vaccine Meets Criteria for Emergency Use

Johnson & Johnson COVID-19 Vaccine Meets Criteria for Emergency Use

Johnson & Johnson (J&J) single-dose Janssen COVID-19 vaccine is one step closer to final FDA approval for emergency use authorization. FDA scientists confirmed the claims made on the vaccine manufacturer’s application to be accurate. The findings were announced on Feb. 24, 2021, two days ahead of the scheduled meeting to discuss the scientific data and […]